Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Aug 6, 2015, after the close
10-Q filed Aug 6, 2015, 37 days after period end · 0001171843-15-004444
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Revenue | $28.80M | $26.96M | $26.09M | $28.50M |
| Net Income | $349.00K | $1.02M | -$186.00K | $774.00K |
| EPS Diluted | $0.01 |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| $0.03 |
| -$0.01 |
| $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
